Clinical trial Recruiting at 1 site Interventional Ages 5 Months to 2

In-home intervention for infants at risk of cerebral palsy

Official title: Feasibility of an In-home Standing and Walking Intervention for Infants With and at High Risk of Cerebral Palsy

Run by University of Southern California · NCT05781438 · Data updated 2026-11-12

This study is testing whether a special in-home program that helps infants at risk of cerebral palsy practice standing and walking can improve their motor skills.

More Cerebral Palsy trials

Quick facts

Study typeInterventional
Ages5 Months to 2 Years
SexAll
Enrollment8 (estimated)
SponsorUniversity of Southern California
Academic / other
Locations1 site (Los Angeles, California)
StatusRecruiting
StartedMarch 26, 2023
Main results expectedDecember 31, 2026
Study endsDecember 31, 2026
Registry record updatedJune 26, 2025
Trial IDNCT05781438 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are infants aged 5 to 12 months who have been diagnosed with cerebral palsy or are at high risk based on specific clinical criteria.

Probably not a fit

Patients with prenatal substance abuse, congenital malformations, or significant sensory impairments may not benefit from this intervention.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study evaluates the feasibility and initial effects of an intensive in-home standing and walking intervention for infants diagnosed with or at high risk of cerebral palsy (CP). Eight infants aged 5 to 12 months will participate in a structured program that includes an 8-week baseline period without intervention, followed by 16 weeks of intervention, and concluding with an 8-week follow-up period. The intervention involves parents implementing standing and walking practices with body-weight support to promote motor development during a critical growth phase. The goal is to optimize future walking outcomes for these infants.

Why it matters

Potential benefit: If successful, this intervention could significantly improve walking outcomes for infants at risk of cerebral palsy.

How similar studies have gone: While this approach is innovative, similar interventions targeting early motor development in infants with CP have shown promise in other studies.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Infants with or at high risk of cerebral palsy (CP) who either:

  * have been diagnosed with CP by a medical professional, or
  * are at high risk of CP defined as having both:

    * clinical brain imaging indicating CP, such as (i) white matter injury (cystic periventricular leukomalacia or periventricular hemorrhagic infarctions), (ii) hypoxic-ischemic encephalopathy, or (iii) neonatal stroke, and
    * a score less than 63 or more than 5 asymmetries on the Hammersmith Infant Neurological Examination (HINE).

Exclusion Criteria:

* prenatal substance abuse,
* congenital malformations,
* drug-resistant epilepsy,
* visual impairment that hinders the infant from seeing toys,
* hearing impairment that hinders the infant from responding to sound,
* living in a location inaccessible by study personnel for in-home data collections,
* participant over 50 lbs in weight.

Where it's running

  • University of Southern California
    Los Angeles, California, United States
    Recruiting

Study contacts

  • Principal investigator: Barbara Sargent, PhD, PT — University of Southern California, Division of Biokinesiology and Physical Therapy
  • Study coordinator: Barbara Sargent, PhD, PT
  • Email: bsargent@pt.usc.edu
  • Phone: 323-442-4823

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.